Sunshine Act Meeting, 36617 [2020-13131]

Download as PDF Federal Register / Vol. 85, No. 117 / Wednesday, June 17, 2020 / Notices DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Foreign Claims Settlement Commission [Docket No. DEA–668] [F.C.S.C. Meeting and Hearing Notice No. 05–20] [Docket No. DEA–667] Importer of Controlled Substances Application: Woodfield Distribution, LLC ACTION: Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City Notice of application. ACTION: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 17, 2020. Such persons may also file a written request for a hearing on the application on or before July 17, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on June 3, 2020, Woodfield Distribution, LLC, 951 Clint Moore Road, Suite A, Boca Raton, Florida 33487–2804, applied to be registered as an importer of the following basic class(es) of controlled substance: Notice of application. DATES: khammond on DSKJM1Z7X2PROD with NOTICES 36617 Controlled substance Drug code Schedule Nabilone .................................. 7379 II Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 17, 2020. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.33(a), this is notice that on May 6, 2020, Cambrex Charles City, 1205 11th Street, Charles City, Iowa 50616–3466, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: SUPPLEMENTARY INFORMATION: Drug code Controlled substance Gamma Hydroxybutyric Acid .. Amphetamine .......................... Lisdexamfetamine ................... Methylphenidate ...................... ANPP (4-Anilino-N-phenethyl4-piperidine). Phenylacetone ........................ Codeine ................................... Oxycodone .............................. Hydromorphone ...................... Hydrocodone ........................... Morphine ................................. Oripavine ................................. Thebaine ................................. Opium extracts ........................ Opium fluid extract .................. Opium tincture ........................ Opium, powdered ................... Oxymorphone ......................... Noroxymorphone .................... Fentanyl .................................. Schedule 2010 1100 1205 1724 8333 I II II II II 8501 9050 9143 9150 9193 9300 9330 9333 9610 9620 9630 9639 9652 9668 9801 II II II II II II II II II II II II II II II The company plans to import this controlled substance for phase I of a clinical study. Approval of permit applications will occur only when the registrant’s activity is consistent with what is authorized under 21 U.S.C. 952(a) (2). Authorization will not extend to the import of Food and Drug Administration (FDA)-approved or nonapproved finished dosage forms for commercial sale. The company plans to manufacture the above-listed controlled substances in bulk for conversion to other controlled substances and sales to its customers for dosage form development, clinical trials and use in stability qualification studies. No other activities for these drug codes are authorized for this registration. William T. McDermott, Assistant Administrator. William T. McDermott, Assistant Administrator. [FR Doc. 2020–13008 Filed 6–16–20; 8:45 am] [FR Doc. 2020–13009 Filed 6–16–20; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 4410–09–P VerDate Sep<11>2014 16:44 Jun 16, 2020 Jkt 250001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 Sunshine Act Meeting The Foreign Claims Settlement Commission, pursuant to its regulations and the Government in the Sunshine Act, hereby gives notice in regard to the scheduling of open meetings as follows: DATES: Thursday, June 25, 2020, at 10 a.m. PLACE: This meeting will be held by teleconference. There will be no physical meeting place. STATUS: Open. Members of the public who wish to observe the meeting via teleconference should contact Patricia M. Hall, Foreign Claims Settlement Commission, Tele: (202) 616–6975, two business days in advance of the meeting. Individuals will be given callin information upon notice of attendance to the Commission. MATTERS TO BE CONSIDERED: 10:00 a.m.—Issuance of Proposed Decisions under the Guam World War II Loyalty Recognition Act, Title XVII, Public Law 114–328. CONTACT PERSON FOR MORE INFORMATION: Requests for information, advance notices of intention to observe an open meeting, and requests for teleconference dial-in information may be directed to: Patricia M. Hall, Foreign Claims Settlement Commission, 441 G St NW, Room 6234, Washington, DC 20579. Telephone: (202) 616–6975. SUMMARY: Brian M. Simkin, Chief Counsel. [FR Doc. 2020–13131 Filed 6–15–20; 4:15 pm] BILLING CODE 4410–BA–P DEPARTMENT OF JUSTICE [OMB Number 1122–0029] Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection Office on Violence Against Women, Department of Justice. ACTION: 30-Day notice. AGENCY: The Department of Justice, Office on Violence Against Women (OVW) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in SUMMARY: E:\FR\FM\17JNN1.SGM 17JNN1

Agencies

[Federal Register Volume 85, Number 117 (Wednesday, June 17, 2020)]
[Notices]
[Page 36617]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-13131]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Foreign Claims Settlement Commission

[F.C.S.C. Meeting and Hearing Notice No. 05-20]


Sunshine Act Meeting

SUMMARY: The Foreign Claims Settlement Commission, pursuant to its 
regulations and the Government in the Sunshine Act, hereby gives notice 
in regard to the scheduling of open meetings as follows:

DATES: Thursday, June 25, 2020, at 10 a.m.

PLACE:  This meeting will be held by teleconference. There will be no 
physical meeting place.

STATUS:  Open. Members of the public who wish to observe the meeting 
via teleconference should contact Patricia M. Hall, Foreign Claims 
Settlement Commission, Tele: (202) 616-6975, two business days in 
advance of the meeting. Individuals will be given call-in information 
upon notice of attendance to the Commission.

MATTERS TO BE CONSIDERED:  10:00 a.m.--Issuance of Proposed Decisions 
under the Guam World War II Loyalty Recognition Act, Title XVII, Public 
Law 114-328.

CONTACT PERSON FOR MORE INFORMATION:  Requests for information, advance 
notices of intention to observe an open meeting, and requests for 
teleconference dial-in information may be directed to: Patricia M. 
Hall, Foreign Claims Settlement Commission, 441 G St NW, Room 6234, 
Washington, DC 20579. Telephone: (202) 616-6975.

Brian M. Simkin,
Chief Counsel.
[FR Doc. 2020-13131 Filed 6-15-20; 4:15 pm]
BILLING CODE 4410-BA-P